Manulife (Manufacturers Life Insurance)
TGTX icon

Manulife (Manufacturers Life Insurance)’s TG Therapeutics TGTX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.39M Sell
71,852
-267
-0.4% -$7.96K ﹤0.01% 1433
2025
Q4 		$2.15M Sell
72,119
-2,849
-4% -$93K ﹤0.01% 1488
2025
Q3 		$2.71M Sell
74,968
-4,402
-6% -$145K ﹤0.01% 1410
2025
Q2 		$2.86M Sell
79,370
-1,755
-2% -$65.3K ﹤0.01% 1362
2025
Q1 		$3.2M Buy
81,125
+5,798
+8% +$195K ﹤0.01% 1327
2024
Q4 		$2.27M Sell
75,327
-3,864
-5% -$111K ﹤0.01% 1504
2024
Q3 		$1.85M Sell
79,191
-1,473
-2% -$32.2K ﹤0.01% 1592
2024
Q2 		$1.44M Buy
80,664
+2,871
+4% +$45.8K ﹤0.01% 1646
2024
Q1 		$1.18M Buy
77,793
+7,578
+11% +$121K ﹤0.01% 1766
2023
Q4 		$1.2M Sell
70,215
-1,224
-2% -$14.2K ﹤0.01% 1712
2023
Q3 		$597K Buy
71,439
+1,634
+2% +$22.8K ﹤0.01% 2042
2023
Q2 		$1.73M Buy
69,805
+15,566
+29% +$402K ﹤0.01% 1450
2023
Q1 		$816K Buy
54,239
+2,198
+4% +$33.4K ﹤0.01% 1725
2022
Q4 		$616K Buy
52,041
+1,795
+4% +$13K ﹤0.01% 1849
2022
Q3 		$297K Sell
50,246
-2,227
-4% -$14.6K ﹤0.01% 2314
2022
Q2 		$223K Buy
52,473
+1,267
+2% +$7.91K ﹤0.01% 2586
2022
Q1 		$487K Sell
51,206
-12,210
-19% -$141K ﹤0.01% 2220
2021
Q4 		$1.21K Buy
63,416
+95
+0.2% +$2.47K ﹤0.01% 1719
2021
Q3 		$2.11M Sell
63,321
-6,069
-9% -$188K ﹤0.01% 1483
2021
Q2 		$2.69M Buy
69,390
+3,610
+5% +$142K ﹤0.01% 1497
2021
Q1 		$3.17M Sell
65,780
-514
-0.8% -$24.7K ﹤0.01% 1411
2020
Q4 		$3.45M Buy
66,294
+5,069
+8% +$171K ﹤0.01% 1366
2020
Q3 		$1.64M Buy
61,225
+5,795
+10% +$133K ﹤0.01% 1479
2020
Q2 		$1.03M Buy
55,430
+2,539
+5% +$40.9K ﹤0.01% 1599
2020
Q1 		$520K Buy
52,891
+5,385
+11% +$68K ﹤0.01% 1816
2019
Q4 		$527K Sell
47,506
-1,342
-3% -$10.2K ﹤0.01% 2015
2019
Q3 		$276K Buy
48,848
+1,092
+2% +$7.61K ﹤0.01% 2373
2019
Q2 		$413K Buy
47,756
+7,436
+18% +$56.2K ﹤0.01% 2162
2019
Q1 		$324K Sell
40,320
-69
-0.2% -$373 ﹤0.01% 2238
2018
Q4 		$165K Sell
40,389
-718
-2% -$3.57K ﹤0.01% 2368
2018
Q3 		$230K Sell
41,107
-1,856
-4% -$21.2K ﹤0.01% 2682
2018
Q2 		$565K Buy
42,963
+6,184
+17% +$85K ﹤0.01% 2288
2018
Q1 		$522K Sell
36,779
-1,977
-5% -$25.3K ﹤0.01% 2299
2017
Q4 		$318K Buy
38,756
+2,359
+6% +$20.6K ﹤0.01% 2647
2017
Q3 		$431K Sell
36,397
-357
-1% -$4.07K ﹤0.01% 2381
2017
Q2 		$370K Buy
36,754
+7,630
+26% +$85.4K ﹤0.01% 2522
2017
Q1 		$340K Buy
29,124
+1,623
+6% +$11.7K ﹤0.01% 2455
2016
Q4 		$128K Buy
27,501
+1,837
+7% +$10.8K ﹤0.01% 3099
2016
Q3 		$199K Sell
25,664
-557
-2% -$3.58K ﹤0.01% 2780
2016
Q2 		$159K Buy
26,221
+3,053
+13% +$24.8K ﹤0.01% 2901
2016
Q1 		$203K Buy
23,168
+224
+1% +$1.96K ﹤0.01% 2589
2015
Q4 		$274 Buy
22,944
+484
+2% +$6.11K ﹤0.01% 2423
2015
Q3 		$226 Buy
22,460
+383
+2% +$5.71K ﹤0.01% 2556
2015
Q2 		$366 Buy
22,077
+4,489
+26% +$71.1K ﹤0.01% 2346
2015
Q1 		$272 Buy
17,588
+1,952
+12% +$29.6K ﹤0.01% 2509
2014
Q4 		$248 Buy
15,636
+586
+4% +$7.63K ﹤0.01% 2491
2014
Q3 		$161 Sell
15,050
-436
-3% -$4.04K ﹤0.01% 2784
2014
Q2 		$145K Buy
+15,486
New +$99K ﹤0.01% 2960
2014
Q1 		– Hold
0
– – – 3197

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s TGTX Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its TG Therapeutics (TGTX) stake by 0.37% in Q1 2026, selling an estimated $7.96K and leaving 71,852 shares worth $2.39M. The position accounts for ﹤0.01% of the portfolio, ranked #1433.

Manulife (Manufacturers Life Insurance) first reported a position in TGTX in Q2 2014 and has held it in 48 quarters since. The position peaked at $3.45M in Q4 2020. 363 funds tracked by Wall St. Rank hold TGTX as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 71,852 shares of TG Therapeutics worth $2.39M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 267 TG Therapeutics shares in Q1 2026, an estimated $7.96K.
  • TG Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1433 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in TG Therapeutics in Q2 2014 and has held it in 48 quarters since.
  • Manulife (Manufacturers Life Insurance)'s TG Therapeutics position peaked at $3.45M in Q4 2020.
  • 363 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.